Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.14.5 extracted from

  • Rosenstock, J.; Zinman, B.
    Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus (2007), Curr. Opin. Endocrinol. Diabetes Obes., 14, 98-107.
    View publication on PubMed

Application

Application Comment Organism
medicine oral dipeptidyl peptidase-4 inhibitors may prove valuable in the treatment of diabetes, given their effectiveness in reducing glycated hemoglobin with neutral weight effects and without the adverse events associated with other agents. Dipeptidyl peptidase-4 inhibitors appear to improve islet function and may modify the course of diabetes Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
sitagliptin
-
Homo sapiens
vildagliptin
-
Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Synonyms

Synonyms Comment Organism
dipeptidyl peptidase-4
-
Homo sapiens
DPP-4
-
Homo sapiens